Compounds > ribavirin
Page last updated: 2024-08-16

ribavirin and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

ribavirin has been researched along with (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (9.09)29.6817
2010's10 (90.91)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akuta, N; Arase, Y; Hosaka, T; Ikeda, K; Kobayashi, M; Kumada, H; Miyakawa, Y; Sezaki, H; Suzuki, F; Suzuki, Y; Yatsuji, H1
Antinori, S; Caramma, I; Cesari, M; Galli, M; Mazzali, C; Milazzo, L; Olivetti, M1
Hokari, A1
Atsukawa, M; Fukuda, T; Itokawa, N; Kanazawa, H; Kidokoro, H; Kobayashi, T; Kondo, C; Matsushita, Y; Nakatsuka, K; Narahara, Y; Sakamoto, C; Tsubota, A1
Atsukawa, M; Fukuda, T; Hashimoto, S; Itokawa, N; Kanazawa, H; Kidokoro, H; Kobayashi, T; Kondo, C; Matsushita, Y; Nakatsuka, K; Narahara, Y; Sakamoto, C; Tsubota, A1
Abd-Eldaem, AA; Ahmad, YK; Azmy, MK; Badr, GA; El-Dahshan, T; Houssein, MA1
Chen, Y; Han, Q; Li, N; Liu, X; Liu, Z; Lv, Y; Yang, C; Zeng, X; Zhang, P; Zhu, Q1
Aston, CE; Bader, T; Dunnam, M; Fazili, J; Frost, B; Gonterman, A; Hughes, LD; Madhoun, M1
Baklan, Z; Kotar, T; Lesnicar, G; Maticic, M; Meglic Volkar, J; Poljak, M; Prah, J; Rajter, M; Selic Kurincic, T1
Kashiwagi, Y; Kawashima, H; Nagao, R; Nishimata, S; Suzuki, S; Tsutsumi, N1
Gabr, HA; Marzaban, RN; Mokhles, MA; Salama, ZA; Seyam, MS; Soliman, AF1

Reviews

2 review(s) available for ribavirin and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

ArticleYear
[Improved virologic response in chronic hepatitis C treated with peginterferon, ribavirin and add-on drug].
    Nihon rinsho. Japanese journal of clinical medicine, 2011, Volume: 69 Suppl 4

    Topics: Antiviral Agents; Cyclosporine; Diterpenes; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Fatty Alcohols; Female; Fluvastatin; Hepatitis C, Chronic; Humans; Indoles; Interferon-alpha; Male; Metformin; Nitro Compounds; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Silybin; Silymarin; Thiazoles

2011
Statin therapy improves response to interferon alfa and ribavirin in chronic hepatitis C: a systematic review and meta-analysis.
    Antiviral research, 2013, Volume: 98, Issue:3

    Topics: Adjuvants, Immunologic; Antiviral Agents; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Fluvastatin; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Indoles; Interferon-alpha; Odds Ratio; Randomized Controlled Trials as Topic; Ribavirin; Treatment Outcome; Viral Load

2013

Trials

7 trial(s) available for ribavirin and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

ArticleYear
Fluvastatin as an adjuvant to pegylated interferon and ribavirin in HIV/hepatitis C virus genotype 1 co-infected patients: an open-label randomized controlled study.
    The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:4

    Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Female; Fluvastatin; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Indoles; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome; Viral Load

2010
An open-label randomized controlled study of pegylated interferon/ribavirin combination therapy for chronic hepatitis C with versus without fluvastatin.
    Journal of viral hepatitis, 2012, Volume: 19, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Antiviral Agents; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Female; Fluvastatin; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Indoles; Interferons; Interleukins; Male; Middle Aged; Ribavirin; Sex Factors; Treatment Outcome; Viral Load

2012
Combination of fluvastatin with pegylated interferon/ribavirin therapy reduces viral relapse in chronic hepatitis C infected with HCV genotype 1b.
    Journal of gastroenterology and hepatology, 2013, Volume: 28, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Confidence Intervals; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Female; Fluvastatin; Hepacivirus; Hepatitis C, Chronic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Interferon alpha-2; Interferon-alpha; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Polyethylene Glycols; Recombinant Proteins; Recurrence; Ribavirin; RNA, Viral

2013
Role of statins in the treatment of chronic hepatitis C virus infection.
    Journal of the Egyptian Society of Parasitology, 2012, Volume: 42, Issue:3

    Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Female; Fluvastatin; Hepacivirus; Hepatitis C, Chronic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Interferon-alpha; Liver; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Viral Load; Virus Replication

2012
A randomized controlled trial adding fluvastatin to peginterferon and ribavirin for naïve genotype 1 hepatitis C patients.
    Journal of viral hepatitis, 2013, Volume: 20, Issue:9

    Topics: Adult; Aged; Antiviral Agents; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Fatty Acids, Monounsaturated; Fluvastatin; Genotype; Hepacivirus; Hepatitis C; Humans; Indoles; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome

2013
Impact of added fluvastatin to standard-of-care treatment on sustained virological response in naïve chronic hepatitis C Patients infected with genotypes 1 and 3.
    Intervirology, 2014, Volume: 57, Issue:1

    Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Female; Fluvastatin; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Indoles; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Treatment Outcome

2014
Evaluation of fluvastatin in combination with the standard of care therapy (PEG-IFN/Ribavirin) in Egyptian patients with hepatitis C virus.
    The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2015, Volume: 26, Issue:6

    Topics: Adult; Antiviral Agents; Blood Cell Count; Drug Therapy, Combination; Egypt; Fatty Acids, Monounsaturated; Female; Fluvastatin; Hepacivirus; Hepatitis C; Humans; Indoles; Interferon-alpha; Liver Function Tests; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Standard of Care; Treatment Outcome

2015

Other Studies

2 other study(ies) available for ribavirin and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

ArticleYear
An open pilot study exploring the efficacy of fluvastatin, pegylated interferon and ribavirin in patients with hepatitis C virus genotype 1b in high viral loads.
    Intervirology, 2009, Volume: 52, Issue:1

    Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Female; Fluvastatin; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Pilot Projects; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome; Viral Load

2009
Efficacy of re-treatment by peginterferon alpha-2a and ribavirin in a child with hepatitis C.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2014, Volume: 20, Issue:7

    Topics: Antiviral Agents; Child; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Fluvastatin; Hepatitis C, Chronic; Humans; Indoles; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome

2014